News Highlights

January 4, 2010
Concert Pharmaceuticals to Present at the 28th
Annual J.P. Morgan Healthcare Conference on Monday,
January 11

December 9, 2009
Concert Pharmaceuticals Broadens Management Team and Expands Product Advisory Board

November 9, 2009
Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV; Concert Earns $12 Million Milestone from GlaxoSmithKline

October 29, 2009
Concert Pharmaceuticals’ Roger Tung Awarded 2009
Mass High Tech All Star Award

more...

Welcome to Concert

Concert uses deuterium-based chemistry to create and develop highly differentiated new medicines by leveraging proven drugs. This approach results in:

• Reduced risk;
• Rapid R&D;
• Clinically differentiated new medicines; and
• Long patent life.
  

Upcoming Events

Concert will present at the Cowen and Company 30th Annual Healthcare Conference at 2:00 p.m. on Monday, March 8, 2010 in Boston.

Concert in the news... a selection of news stories featuring Concert.